Xenon Pharmaceuticals Announces Exercise In Full Of Option To Purchase Additional Shares And Closing Of $34.5 Million Public Offering

Xenon Pharmaceuticals Inc., today announced that the underwriters of the previously announced public offering of its common shares have exercised in full their option to purchase an additional 600,000 common shares.